Search

Your search keyword '"Giaccari, Andrea"' showing total 503 results

Search Constraints

Start Over You searched for: Author "Giaccari, Andrea" Remove constraint Author: "Giaccari, Andrea"
503 results on '"Giaccari, Andrea"'

Search Results

4. Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes

5. Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes

6. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk

7. Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes

8. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study

11. Beta-cell function and glucose metabolism in patients with chronic pancreatitis

13. Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes

14. Italian guidelines for the treatment of type 2 diabetes

15. Reduced incretin effect precedes diabetes development following duodenopancreatectomy in subjects without diabetes

16. Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk

22. Oral or injectable semaglutide for the management of type 2 diabetes in routine care: A multicentre observational study comparing matched cohorts.

23. Advancing Diabetes Research: A Novel Islet Isolation Method from Living Donors.

24. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

26. Comprehensive IsomiR sequencing profile of human pancreatic islets and EndoC-βH1 beta-cells

27. Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes

28. Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study

32. Erythrocyte membrane fluidity: A novel biomarker of residual cardiovascular risk in type 2 diabetes.

34. Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes

35. Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function

39. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study

40. Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release.

42. Identification and Molecular Characterization of a Novel Large-Scale Variant (Exons 4_18 Loss) in the LDLR Gene as a Cause of Familial Hypercholesterolaemia in an Italian Family

43. #4772 DOUBLE FILTRATION PLASMAPHERESIS DURING HETEROLOGOUS FERTILIZATION PREGNANCY FOR THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA

44. Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study

45. Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia

47. Pancreaticoduodenectomy model demonstrates a fundamental role of dysfunctional [beta] cells in predicting diabetes

48. Why do some glucose‐lowering agents improve non‐alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis.

50. Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features

Catalog

Books, media, physical & digital resources